Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1927 2
1930 1
1931 2
1933 1
1945 1
1947 1
1949 4
1950 3
1952 2
1953 2
1954 1
1955 1
1958 3
1959 3
1960 4
1961 1
1962 3
1963 2
1964 4
1965 6
1966 7
1967 11
1968 9
1969 7
1970 9
1971 8
1972 11
1973 7
1974 7
1975 11
1976 9
1977 7
1978 6
1979 22
1980 8
1981 10
1982 18
1983 17
1984 19
1985 27
1986 25
1987 23
1988 26
1989 16
1990 27
1991 25
1992 17
1993 17
1994 20
1995 19
1996 18
1997 26
1998 28
1999 24
2000 30
2001 26
2002 34
2003 35
2004 46
2005 48
2006 35
2007 47
2008 67
2009 64
2010 47
2011 62
2012 60
2013 82
2014 76
2015 89
2016 73
2017 71
2018 64
2019 59
2020 94
2021 80
2022 87
2023 75
2024 72
2025 53

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,975 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: smith ad. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Free PMC article. Clinical Trial.
Nutrition and the ageing brain: Moving towards clinical applications.
Flanagan E, Lamport D, Brennan L, Burnet P, Calabrese V, Cunnane SC, de Wilde MC, Dye L, Farrimond JA, Emerson Lombardo N, Hartmann T, Hartung T, Kalliomäki M, Kuhnle GG, La Fata G, Sala-Vila A, Samieri C, Smith AD, Spencer JPE, Thuret S, Tuohy K, Turroni S, Vanden Berghe W, Verkuijl M, Verzijden K, Yannakoulia M, Geurts L, Vauzour D. Flanagan E, et al. Among authors: smith ad. Ageing Res Rev. 2020 Sep;62:101079. doi: 10.1016/j.arr.2020.101079. Epub 2020 May 24. Ageing Res Rev. 2020. PMID: 32461136 Free article. Review.
Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies.
Garcia L, Pearce M, Abbas A, Mok A, Strain T, Ali S, Crippa A, Dempsey PC, Golubic R, Kelly P, Laird Y, McNamara E, Moore S, de Sa TH, Smith AD, Wijndaele K, Woodcock J, Brage S. Garcia L, et al. Among authors: smith ad. Br J Sports Med. 2023 Aug;57(15):979-989. doi: 10.1136/bjsports-2022-105669. Epub 2023 Feb 28. Br J Sports Med. 2023. PMID: 36854652 Free PMC article.
Vitamin B-12.
Sobczyńska-Malefora A, Smith AD. Sobczyńska-Malefora A, et al. Among authors: smith ad. Adv Nutr. 2022 Oct 2;13(5):2061-2063. doi: 10.1093/advances/nmac030. Adv Nutr. 2022. PMID: 35348594 Free PMC article. No abstract available.
The importance of vitamin B12 for individuals choosing plant-based diets.
Niklewicz A, Smith AD, Smith A, Holzer A, Klein A, McCaddon A, Molloy AM, Wolffenbuttel BHR, Nexo E, McNulty H, Refsum H, Gueant JL, Dib MJ, Ward M, Murphy M, Green R, Ahmadi KR, Hannibal L, Warren MJ, Owen PJ; CluB-12. Niklewicz A, et al. Among authors: smith ad. Eur J Nutr. 2023 Apr;62(3):1551-1559. doi: 10.1007/s00394-022-03025-4. Epub 2022 Dec 5. Eur J Nutr. 2023. PMID: 36469110 Free PMC article.
Generative Artificial Intelligence.
Lee CI, Chen JH, Kohli MD, Smith AD, Liao JM. Lee CI, et al. Among authors: smith ad. J Am Coll Radiol. 2024 Aug;21(8):1318-1320. doi: 10.1016/j.jacr.2024.01.020. Epub 2024 Feb 1. J Am Coll Radiol. 2024. PMID: 38295922 Free PMC article. No abstract available.
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination.
Arance A, de la Cruz-Merino L, Petrella TM, Jamal R, Ny L, Carneiro A, Berrocal A, Márquez-Rodas I, Spreafico A, Atkinson V, Costa Svedman F, Mant A, Khattak MA, Mihalcioiu C, Jang S, Cowey CL, Smith AD, Hawk N, Chen K, Diede SJ, Krepler C, Long GV. Arance A, et al. Among authors: smith ad. J Clin Oncol. 2023 Jan 1;41(1):75-85. doi: 10.1200/JCO.22.00221. Epub 2022 Jul 22. J Clin Oncol. 2023. PMID: 35867951 Clinical Trial.
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lee CH, Shah AY, Rasco D, Rao A, Taylor MH, Di Simone C, Hsieh JJ, Pinto A, Shaffer DR, Girones Sarrio R, Cohn AL, Vogelzang NJ, Bilen MA, Gunnestad Ribe S, Goksel M, Tennøe ØK, Richards D, Sweis RF, Courtright J, Heinrich D, Jain S, Wu J, Schmidt EV, Perini RF, Kubiak P, Okpara CE, Smith AD, Motzer RJ. Lee CH, et al. Among authors: smith ad. Lancet Oncol. 2021 Jul;22(7):946-958. doi: 10.1016/S1470-2045(21)00241-2. Epub 2021 Jun 15. Lancet Oncol. 2021. PMID: 34143969 Free PMC article. Clinical Trial.
1,975 results